Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1102-1109, 2005; 10.1373/clinchem.2004.047084
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, M. Y.
Right arrow Articles by Ballantyne, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, M. Y.
Right arrow Articles by Ballantyne, C. M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2005;51:1102-1109.)
© 2005 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System

Mine Y. Liu1, Antonios M. Xydakis2, Ron C. Hoogeveen1, Peter H. Jones1, E. O’Brian Smith3, Kathleen W. Nelson4 and Christie M. Ballantyne1,a

1 Section of Atherosclerosis, Department of Medicine, 2 Division of Endocrinology, Diabetes and Metabolism, and 3 Section of Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
4 Methodist Wellness Services, The Methodist Hospital, Houston, TX.

aAddress correspondence to this author at: Baylor College of Medicine, 6565 Fannin, M.S. A-601, Houston, TX 77030. Fax 713-798-3057; e-mail cmb{at}bcm.tmc.edu.

Background: The complex pathology of disease has sparked the development of novel protein expression profiling techniques that require validation in clinical settings. This study focuses on multiplexed analyses of adipocytokines and biomarkers linked to the metabolic syndrome, diabetes, and cardiovascular disease.

Methods: Multiplexed immunoassays using fluorescent microspheres and the Luminex-100 system were performed on plasma from 80 obese patients (40 with the metabolic syndrome) before and after 6–8 weeks of diet-induced weight loss. Leptin, insulin, C-peptide, monocyte chemoattractant protein-1 (MCP-1), eotaxin, interleukin-8 (IL-8), tumor necrosis factor-{alpha} (TNF-{alpha}), and IL-6 concentrations measured with multiplex panels from 3 different manufacturers were compared with results from commercial ELISAs. Detection limits and between- and within-run imprecision were determined for each analyte. Bland–Altman analysis was used to determine agreement between multiplexed immunoassays and ELISAs.

Results: Correlation between the Luminex multiplexed assays and ELISAs was good for leptin (Linco), insulin (Linco), MCP-1 (Biosource and Upstate), and eotaxin (Biosource) with correlation coefficients of 0.711–0.895; fair for eotaxin (Upstate) and C-peptide (Linco) with correlation coefficients of 0.496–0.582; and poor for TNF-{alpha}, IL-8, and IL-6 (Linco, Biosource, Upstate, and R&D) with correlation coefficients of –0.107 to 0.318. Within- and between-run imprecision values for the multiplex method were generally <15%. Relative changes in plasma leptin and insulin concentrations after diet-induced weight loss were similar whether assessed by multiplex assay or ELISA.

Conclusion: Although this technology appears useful in clinical research studies, low assay sensitivity and poor correlations with conventional ELISA methods for some analytes with very low plasma concentrations should be considered when using the Luminex platform in clinical studies.




The following articles in journals at HighWire Press have cited this article:


Home page
 Eur J EndocrinolHome page
E.-M. Sedlmeier, H. Grallert, C. Huth, H. Lowel, C. Herder, K. Strassburger, G. Giani, H-E. Wichmann, H. Hauner, T. Illig, et al.
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg
Eur. J. Endocrinol., March 1, 2007; 156(3): 377 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. P F Dullaart, R. de Vries, A. van Tol, and W. J Sluiter
Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender
Eur. J. Endocrinol., March 1, 2007; 156(3): 387 - 394.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
F. Poulsen and K. B. Jensen
A Luminescent Oxygen Channeling Immunoassay for the Determination of Insulin in Human Plasma
J Biomol Screen, March 1, 2007; 12(2): 240 - 247.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
N. Rifai and R. E. Gerszten
Biomarker Discovery and Validation
Clin. Chem., September 1, 2006; 52(9): 1635 - 1637.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. Kofoed, U. V. Schneider, T. Scheel, O. Andersen, and J. Eugen-Olsen
Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology
Clin. Chem., July 1, 2006; 52(7): 1284 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Xu, Y. Wang, J. Y. Xu, D. Stejskal, S. Tam, J. Zhang, N. M.S. Wat, W. K. Wong, and K. S.L. Lam
Adipocyte Fatty Acid-Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome
Clin. Chem., March 1, 2006; 52(3): 405 - 413.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.